Form 4: Life360 Director Chris Hulls Granted 26,499 RSUs

Life360, Inc. Director Chris Hulls received a grant of 26,499 restricted stock units, vesting monthly from September 2025.

Summary

• Chris Hulls, a Director of Life360, Inc., was granted 26,499 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of common stock upon settlement.
• The RSUs will vest monthly at a rate of 1/48th, commencing September 1, 2025, contingent on continuous service.
• Following this transaction, Chris Hulls directly beneficially owns 483,830 shares, which includes 151,934 previously granted RSUs.
• Indirect beneficial ownership includes 195,312 shares each held by the Robin Hulls 2023 Irrevocable Trust, Rose Hulls 2023 Irrevocable Trust, and Mckenzie Hulls 2023 Irrevocable Trust, all underlying CDIs and subject to a lock-up agreement.
• An additional 1,846 shares are indirectly held through ICCA Labs, LLC, representing his proportionate ownership.

Sentiment

Score: 7

Explanation: The RSU grant is a positive for aligning director interests and retention, but it's a routine compensation event rather than a significant operational or financial announcement. The lock-up on indirect holdings is a minor negative for liquidity but not a major concern.

Positives

• The grant of 26,499 Restricted Stock Units (RSUs) to Director Chris Hulls aligns his interests with long-term shareholder value.
• The vesting schedule, commencing September 1, 2025, incentivizes continuous service and commitment to the company's future performance.

Negatives

• The newly granted RSUs do not represent immediate cash compensation or an outright share transfer, as they are contingent on future vesting.
• A significant portion of indirect holdings (585,938 CDIs underlying 195,312 shares per trust) remains subject to a lock-up agreement, restricting immediate liquidity.

Risks

• The vesting of RSUs is contingent on Chris Hulls' continuous service, meaning unvested units could be forfeited if service terminates.
• Shares held indirectly by the irrevocable trusts, underlying CDIs, are subject to a lock-up agreement, limiting their liquidity until the lock-up expires.

Future Outlook

The grant of Restricted Stock Units (RSUs) to Director Chris Hulls includes a vesting schedule of 1/48th monthly, commencing September 1, 2025, contingent on his continuous service to the company.

Industry Context

This Form 4 filing reflects a standard practice of granting equity compensation to directors, a common mechanism in the technology sector to align executive and director interests with long-term shareholder value and encourage retention. Such grants are typical for growth-oriented companies like Life360, which often use equity to compensate key personnel.

Comparison to Industry Standards

• The grant of Restricted Stock Units (RSUs) to a director is a common compensation practice across the technology industry, comparable to equity incentive programs at companies like Apple, Google, or Meta, which frequently use RSUs to incentivize and retain key executives and board members.
• The 4-year monthly vesting schedule (implied by 1/48th monthly) is also a standard duration for such grants, ensuring long-term commitment.

Related Party Transactions

• Indirect beneficial ownership through the Robin Hulls 2023 Irrevocable Trust, Rose Hulls 2023 Irrevocable Trust, and Mckenzie Hulls 2023 Irrevocable Trust.
• Indirect beneficial ownership through ICCA Labs, LLC, where the reporting person is a member.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with long-term shareholder value, potentially leading to more focused decision-making for company growth.
• Employees: No direct impact on general employees, but it reinforces the company's use of equity as an incentive.
• Management: The grant incentivizes the director to remain engaged and contribute to the company's strategic direction.

Next Steps

• Chris Hulls' RSUs will begin vesting monthly from September 1, 2025, over a 48-month period.
• Chris Hulls must maintain continuous service to the company for the RSUs to vest.

Key Dates

Recommendation

This Form 4 filing details a routine equity grant to a director, which is a standard compensation practice and does not provide new information that would fundamentally alter the investment thesis for Life360. While the grant aligns director interests with shareholders, it's not a catalyst for significant price movement. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

Life360, LIF, Chris Hulls, Form 4, SEC filing, Restricted Stock Units, RSUs, Director compensation, beneficial ownership, stock grant, corporate governance, insider transaction